Navigation Links
One Pill may Be Better Than Two for Treating Patients With High Blood Pressure

Adults with high blood pressure and additional risk factors for heart disease may benefit more from taking one tablet rather than two , if their current treatment combines the lipid-lowering medication atorvastatin with the blood pressure-lowering medication amlodipine, researchers reported at the American Heart Association's 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.

In an analysis, researchers found that a single-tablet combination of the two medications is less costly than a two-tablet combination and is at least as effective, if not more so, in preventing cardiovascular events. Patients take the single-tablet medication or the two-tablet medication daily.

'This is a novel research approach that examines the economic and clinical implications of high blood pressure and cholesterol in the real world,' said Timothy W. Smith, lead author of the study and senior director of Informatics for ValueMedics Research (a unit of IMS Health Inc), a health outcomes research and consulting firm in Falls Church, Va. Researchers used a treatment approach and a population similar to the Anglo-Scandinavian Cardiac Outcomes Trial Lipid-Lowering Arm (ASCOT-LLA), which demonstrated the benefits of adding atorvastatin to high blood pressure treatment in adults with three or more risk factors for heart disease, including abnormal ratio of total-to-high density lipoprotein (HDL the 'good' cholesterol), previous stroke, male gender, 55 years or older and smoking.

In ASCOT-LLA, researchers examined 10,305 patients with high blood pressure and additional risk factors for heart disease with lowto-moderate cholesterol levels and found the addition of atorvastatin to high blood pressure treatment resulted in a significant reduction in unfavorable outcomes: fatal and non-fatal heart attack, stroke and chest pain. Nearly one in three U.S. adults has high blood pressure. About one-third of them do not know they have it. Uncontrolled high blood pressure can lead to stroke, heart attack, heart failure or kidney failure.

High blood pressure is defined as systolic pressure of 140 mm Hg or higher or diastolic pressure of 90 mm Hg or higher. Systolic pressure is the force of blood in the arteries when the heart contracts to pump blood to the body. Diastolic pressure is the force in the arteries when the heart relaxes between beats. Normal blood pressure is less than 120 mm Hg systolic pressure and less than 80 mm Hg diastolic pressure.

The results of the study showed that when hypothetical cohorts of 100,000 people fully adhered to the one-tablet and two-tablet regimens, each treatment group had 3,520 cardiovascular events over four years, such as fatal and non-fatal heart attack, chest pain and stroke. Medical costs over four years were $7,665 for the two-tablet regimen and $6,471 for the one-tablet regimen.

A further analysis, examining the impact of lower compliance more typical in real-world populations, showed that four-year cardiovascular events increased for the two-tablet regimen to 6,990 versus 6,859 for the one-tablet regimen. Researchers concluded the one-tablet regimen was less costly and at least as effective as the two-tablet regimen. Sensitivity analyses confirmed these results when varying the effectiveness associated with partial adherence from 0 percent to 100 percent of the effectiveness of full adherence.

Researchers in the ValueMedics study used U.S. databases to estimate direct medical costs and adverse treatment outcomes over four years among adults with similar characteristics to those examined in ASCOT-LLA. Amlodipine (brand name Norvasc) is in a class of medications called calcium channel blockers. It lowers blood pressure by relaxing the blood vessels so the heart does not have to pump as hard.

Atorvastatin (brand name Lipitor) is in a class of medications known as sta tins or HMG-CoA reductase inhibitors. It lowers the level of cholesterol in the blood.

A single tablet combination of amlodipine/atorvastatin is available as Caduet.


'"/>




Related medicine news :

1. Better prostate cancer detection
2. Better Treatment for obesity
3. For a Better Memory
4. Baby Talk Better Than Adult Speech
5. Drug Combo Works Better for children with ADHD, Tics
6. Better skin with lasers
7. Better diabetes treatment promises Vanadium
8. Better Prostate Cancer Test
9. Better Drug for Heart Transplant
10. Better Diet Even Late in Life May Prolong It
11. Better Care Required for Breast Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... February 10, 2016 , ... A ... Ohio Safety Congress and Expo event March 9-11, 2016. Hosted by Ohio's Bureau ... Center. , As the longest running and largest worker's compensation event in ...
(Date:2/10/2016)... MD (PRWEB) , ... February 10, 2016 , ... ... to make Everseat digital self-scheduling readily available to physicians. The integration ... patients can find and select appointments via Everseat’s free mobile app. , The ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... Jacksonville, FL 32224, February 26th: Amateur & Professional Divisions - Time: 7:00pm ... 7:00pm – 10:00pm | Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org , ...
(Date:2/10/2016)... ... 10, 2016 , ... Workrite Ergonomics, who is celebrating their 25th year of ... to being an internationally recognized leader in their industry. , "We are very proud ... President of Workrite. “Workrite recognized the importance of good ergonomics before most of ...
(Date:2/10/2016)... ... February 10, 2016 , ... Anxiety of older Americans over ... of Medicare Part D a decade ago, according to The Senior Citizens League ... on how they are coping with rapidly rising costs. “The implications are chilling, ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)...  Bluestar Silicones will promote its Silbione® Biomedical ... implant applications and announce certification of its clean ... West Conference (Booth #1759), February 9-10, at the ... --> Available in 01 through 70 ... physical properties enabling our customers to optimize their ...
(Date:2/8/2016)... -- Alzheimer Diagnostic Tests - Medical Devices Pipeline ... sector report , "Alzheimer Diagnostic Tests - Medical ... Alzheimer Diagnostic Tests currently in pipeline stage. ... products with comparative analysis of the products at ... players involved in the pipeline product development. It ...
(Date:2/8/2016)... Devices - Medical Devices Pipeline Assessment, 2015 Summary ... Medical Devices Pipeline Assessment, 2015" provides an overview of ... This report is prepared using data sourced from in-house ... industry experts. *Note: Certain sections in the report ... and relevance of data in relation to the equipment ...
Breaking Medicine Technology: